-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
GlobeStar Therapeutics Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2014 to Q2 2024.
- GlobeStar Therapeutics Corp Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$4.3K, a 32.6% decline year-over-year.
- GlobeStar Therapeutics Corp Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$82.4K, a 170% decline year-over-year.
- GlobeStar Therapeutics Corp annual Nonoperating Income (Expense) for 2023 was -$84.9K, a 61.9% increase from 2022.
- GlobeStar Therapeutics Corp annual Nonoperating Income (Expense) for 2022 was -$223K, a 68.5% increase from 2021.
- GlobeStar Therapeutics Corp annual Nonoperating Income (Expense) for 2021 was -$707K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)